Optimi Health (OPTH) Research & Development (2024 - 2026)
Optimi Health's Research & Development was $148,056 in the quarter ended Jun 30, 2026, up 0.8% from $146,867 a year earlier and up 132.6% from the prior quarter.
Powered by 
Analysis
Optimi Health (OPTH) Research & Development (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Optimi Health's Research & Development was $27,017 through Jun 30, 2026, down 95.4% year-over-year; for the year ended Sep 30, 2025, it was $248,775, down 12.7% from the prior year.
- In earlier years, Research & Development was $284,958 in the year ended Sep 30, 2024 (+152.5%) and $112,845 in the year ended Sep 30, 2023.
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Research & Development since the quarter ended Mar 31, 2025.
- Compared with a year earlier, Research & Development was higher in two of the last four quarters, with an average decline of 31.0%.
- Per Business Quant data, OPTH's Research & Development in the three quarters before the quarter ended Jun 30, 2026 was $63,655 (quarter ended Mar 31, 2026), $34,775 (quarter ended Dec 31, 2025) and -$219,469 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Optimi Health | 9.67 Mn | -791,462.39 | 112,839.24 | 148,055.82 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 148,055.82 |
| Mar 31, 2026 | 63,655.28 |
| Dec 31, 2025 | 34,775.10 |
| Sep 30, 2025 | -219,469.20 |
| Jun 30, 2025 | 146,867.05 |
| Mar 31, 2025 | 170,212.79 |
| Dec 31, 2024 | 144,600.09 |
| Jun 30, 2024 | 129,109.92 |
API Access
Optimi Health Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=OPTH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "OPTH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=OPTH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();